Back

Evolution of SARS-CoV-2 seroprevalence and clusters in school children from June 2020 to April 2021 reflect community transmission: prospective cohort study Ciao Corona

Ulyte, A.; Radtke, T.; Abela, I. A.; Haile, S. R.; Ammann, P.; Berger, C.; Trkola, A.; Fehr, J.; Puhan, M. A.; Kriemler, S.

2021-07-19 epidemiology
10.1101/2021.07.19.21260644 medRxiv
Show abstract

ObjectivesTo longitudinally assess severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence and clustering of seropositive children within school classes in March-April 2021 compared to June-July and October-November 2020. To examine the evolution of symptoms and the extent of under-detection of SARS-CoV-2 in children. DesignProspective cohort study of randomly selected schools and classes. SettingSchools remained open for physical attendance in Switzerland from May 2020 to the end of 2020/2021 school year. Lower school level (age range 7-10 years) and middle school level (8-13 years) children in primary schools, and upper school level (12-17 years) children in secondary schools were invited for SARS-CoV-2 serological testing in the Ciao Corona study in the canton of Zurich, Switzerland. Three testing rounds were completed in June-July 2020 (T1; after the first wave of SARS-CoV-2 infections), October-November 2020 (T2; during the peak of the second wave), and March-April 2021 (T3; after the second wave and with SARS-CoV-2 variants of concern becoming dominant). Parents completed questionnaires on sociodemographic information and symptoms. Participants2487 children (median age 12 years, age range 7-17 years) recruited from 275 classes in 55 schools participated in the testing in March-April 2021; total of 2974 children participated in at least one of the 3 testing rounds. Main outcome measuresSARS-CoV-2 serology results; clustering of seropositive children within classes; reported symptoms. ResultsThe proportion of children who were SARS-CoV-2 seropositive increased from 1.5% (95% credible interval (CrI) 0.6% to 2.6%) in June-July 2020, to 6.6% (95% CrI 4.0% to 8.9%) in October-November, and to 16.4% (95% CrI 12.1% to 19.5%) in March-April 2021. By March-April 2021, children in upper school level (12.4%; 95% CrI 7.3% to 16.7%) were less likely to be seropositive than those in middle (19.5%; 95% CrI 14.2% to 24.4%) or lower school levels (16.0%; 95% CrI 11.0% to 20.4%). Children in the upper school level had a 5.1% (95% CI -9.4% to -0.7%) lower than expected seroprevalence by March-April 2021 than those in middle school level, based on difference-in-differences analysis. The ratio of PCR-diagnosed to all seropositive children changed from 1 to 21.7 (by June-July 2020) to 1 to 3.5 (by March-April 2021). Symptoms were reported by 37% of newly seropositive and 16% seronegative children. Potential clusters of 3 or more newly seropositive children were detected in 24 of 119 (20%) classes with a high participation rate, from which a median of 17 clusters could be expected due to random distribution of seropositive children within the classes. Clustering was lowest in middle and upper school levels. Retention rate in the cohort was high (84% of T1 participants attended T3). Among participants, supporting society and research were reported more commonly for participation than personal reasons. Fear of blood sampling was the most frequently reported reason for non-participation, reported for 64% of children. ConclusionsBy March-April 2021, 16.4% of children and adolescents were seropositive in the canton of Zurich, Switzerland. The majority of clusters of SARS-CoV-2 seropositive children in school classes could be explained by community rather than intra-class transmission of infections. Seroprevalence and clustering was lowest in upper school levels during all timepoints. Trial registrationClinicalTrials.gov NCT04448717. What is already known on the topicO_LITransmission of SARS-CoV-2 in school setting largely followed community transmission in 2020. C_LIO_LIWith implemented preventive measures, secondary attack rates were low and clustering of SARS-CoV-2 infections within classes and schools (outbreaks) were observed rarely. C_LI What this study addsO_LIWith high community incidence and new variants of SARS-CoV-2, seroprevalence increased in school children between October 2020 - March 2021 in the canton of Zurich in Switzerland, and was higher in lower school levels. C_LIO_LIMost of the potential clusters of children who tested seropositive within classes could be explained by community rather than intra-class transmission of SARS-CoV-2, especially in middle and upper school levels. C_LIO_LIMore children who tested seropositive in March-April 2021 were diagnosed and reported symptoms potentially related to SARS-CoV-2 infection more frequently than those who tested seropositive in June-July or October-November 2020. C_LIO_LIThe most frequent reason for non-participation was fear of blood sampling (62% of children). C_LI

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
BMJ
49 papers in training set
Top 0.1%
10.4%
2
Swiss Medical Weekly
12 papers in training set
Top 0.1%
6.8%
3
PLOS Medicine
98 papers in training set
Top 0.5%
6.3%
4
BMJ Open
554 papers in training set
Top 3%
6.3%
5
Eurosurveillance
80 papers in training set
Top 0.1%
6.3%
6
JAMA Network Open
127 papers in training set
Top 0.6%
4.8%
7
The Lancet Infectious Diseases
71 papers in training set
Top 0.5%
4.8%
8
Nature Communications
4913 papers in training set
Top 35%
4.3%
50% of probability mass above
9
International Journal of Epidemiology
74 papers in training set
Top 0.6%
3.6%
10
The Lancet Regional Health - Europe
32 papers in training set
Top 0.1%
2.9%
11
International Journal of Public Health
17 papers in training set
Top 0.1%
2.3%
12
Epidemiology and Infection
84 papers in training set
Top 1%
1.9%
13
Clinical Infectious Diseases
231 papers in training set
Top 3%
1.7%
14
BMC Public Health
147 papers in training set
Top 3%
1.7%
15
The Lancet
16 papers in training set
Top 0.3%
1.7%
16
BMC Medicine
163 papers in training set
Top 4%
1.7%
17
Pediatrics
10 papers in training set
Top 0.1%
1.7%
18
eClinicalMedicine
55 papers in training set
Top 0.6%
1.7%
19
PLOS ONE
4510 papers in training set
Top 55%
1.7%
20
BMJ Paediatrics Open
21 papers in training set
Top 0.5%
1.5%
21
The Lancet Regional Health - Americas
22 papers in training set
Top 0.1%
1.2%
22
The Journal of Infectious Diseases
182 papers in training set
Top 4%
1.1%
23
European Journal of Public Health
20 papers in training set
Top 0.7%
1.1%
24
Vaccine
189 papers in training set
Top 2%
0.9%
25
Emerging Infectious Diseases
103 papers in training set
Top 3%
0.8%
26
Frontiers in Pediatrics
29 papers in training set
Top 0.8%
0.8%
27
The Lancet Public Health
20 papers in training set
Top 0.6%
0.8%
28
International Journal of Infectious Diseases
126 papers in training set
Top 3%
0.8%
29
Influenza and Other Respiratory Viruses
44 papers in training set
Top 0.4%
0.7%
30
Archives of Disease in Childhood
15 papers in training set
Top 0.5%
0.7%